Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

Incubator Microscope

By Drug Discovery Trends Editor | March 15, 2010

Olympus has introduced the VivaView MG (Multi-Gas) incubator microscope, a long-term live cell incubation and imaging system optimized for stem cell, cancer and other research requiring independent control of both oxygen and carbon dioxide levels, along with other environmental parameters. The self-contained system can be adjusted to provide the low oxygen (hypoxia) environmental conditions that many stem cell experiments and other advanced research protocols demand. 

VivaView MG is equipped with nitrogen purging to regulate oxygen levels and more exactly mimic physiological conditions. Controlling oxygen levels in embryonic stem cell work is vital because, in nature, early-developing embryos thrive with much lower levels of oxygen than are present in either the atmosphere, conventional incubators or traditional microscope incubation systems. In non-embryonic stem cell studies, the microenvironment can affect gene regulation and differentiation, so it is important to control oxygen levels when growing such cells in vitro as well. Cartilage, cancerous and other specific tissue types exist in environments with no nearby blood supply; they too must often be studied using lower oxygen levels.  The VivaView MG makes it possible to recreate these conditions during multi-dimensional imaging because it is a true incubator, incorporating a fully automated microscope imaging system driven by Metamorph® for Olympus software. Post-acquisition processing, deconvolution, and analysis can also be achieved with the software.
 
Scientists using the VivaView MG can choose from several new objective lens options, enabling them to adjust the magnification of the imaging system to match both their application and their sample precisely. The lenses include 10x, 20x, and 40x long working distance objectives for phase contrast and fluorescence, along with both 20x and 40x differential interference contrast (DIC) and fluorescence optics for high magnification, high resolution work. All objectives are compatible with the original VivaView (carbon dioxide control only) system.

Olympus VivaView systems allow observation of multiple locations per dish in up to eight dishes simultaneously, for up to a week at a time. Each closed-box system incorporates an incubator, fully enclosed motorized inverted microscope, high-performance drift-free optics, camera, computer and easy-to-use software. VivaView’s streamlined dish management system offers supreme flexibility, ease of use, and optical performance. Scientists can change media in mid-experiment or add medications, drugs or other substances without removing samples from the incubator or disturbing environmental conditions inside. The system allows multiple observations in each dish, at multiple focal points, with intermittent review of results and images, even while the experiment is underway. Cells remain uncontaminated and enjoy a consistently beneficial environment throughout the experimental process.

Olympus


Filed Under: Drug Discovery

 

Related Articles Read More >

Chemical formula of psilocybin
Psychedelic pioneer Compass files for FDA approval as rivals close in
Insilico’s AI-designed TEAD inhibitor shrank tumors in 4 of 22 mesothelioma patients; randomized Phase 2a planned for 2027
If Trump gets Europe to pay more for drugs, more new medicines could follow — eventually
Antibody - visual concept of immune System - 3D illustration
Fresenius picks the biosimilars, WuXi Biologics builds them in a deal covering up to 37 candidates
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Drug Delivery Business News
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Pharmaceutical Processing World
  • R&D World
  • Subscribe to our E-Newsletter
  • About Us
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE